诺瓦瓦克斯股价在第四季度意外实现盈利且营收超出预期后飙升17%

关键事实

1Novavax stock jumped 17% after reporting a surprise profit in Q4.

2Sales soared 67% year-over-year, driven by strong licensing revenues.

3Lower operating costs contributed to the company's swing to profitability during the quarter.

诺瓦瓦克斯（NVAX）股价在其强劲的第四季度财务业绩公布后大幅上涨17%。这家生物技术公司报告了意外盈利，超出了分析师的预期，预示着强劲的运营好转。该季度总营收同比增长67%，主要得益于强劲的许可收入。除了营收增长，该公司还成功实施了成本削减策略，大幅降低了运营开支。收入增加和支出纪律相结合，促使该公司在此期间扭亏为盈。投资者对改善后的财务状况反应积极，重振了对该公司在生物技术领域长期发展轨迹的信心。